Financials
- Market Capitalization 7.59 M
- Employee 8
- Founded 2011
- CEO Paul Kang
- Website www.exicuretx.com
- Headquarter Delaware, United States
- FIGI BBG00GTJCSB4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.86
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4730 | APRE Aprea Therapeutics, Inc. - Common Stock | 0.61 USD | +3.39% | -4.69% | -20.78% | -59.60% | 7.68 M USD | ||
| 4733 | CURX Curanex Pharmaceuticals Inc - Common Stock | 4.88 USD | -8.10% | +1.88% | +10.66% | +674.60% | 7.65 M USD | ||
| 4742 | SNGX Soligenix, Inc. - Common Stock | 0.34 USD | -2.86% | -5.56% | -8.11% | -69.91% | 7.40 M USD | ||
| 4744 | INM InMed Pharmaceuticals Inc. - Common Shares | 1.34 USD | -1.47% | +0.75% | +3.88% | -37.09% | 7.36 M USD |